CA2273199A1 - Sequences nucleotidiques et aminoacides en rapport avec helicobacter pylori et compositions vaccinales correspondantes - Google Patents

Sequences nucleotidiques et aminoacides en rapport avec helicobacter pylori et compositions vaccinales correspondantes Download PDF

Info

Publication number
CA2273199A1
CA2273199A1 CA002273199A CA2273199A CA2273199A1 CA 2273199 A1 CA2273199 A1 CA 2273199A1 CA 002273199 A CA002273199 A CA 002273199A CA 2273199 A CA2273199 A CA 2273199A CA 2273199 A1 CA2273199 A1 CA 2273199A1
Authority
CA
Canada
Prior art keywords
seq
pylori
polypeptide
nucleic acid
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002273199A
Other languages
English (en)
Inventor
Douglas Smith
Richard A. Alm
Peter C. Doig
Zita Kabok
Lillian Marie Castriotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2273199A1 publication Critical patent/CA2273199A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention a trait à des préparations de recombinaison ou sensiblement pures de polypeptides d'H. pylori. Elle porte également sur les acides nucléiques codant ces polypeptides. Les polypeptides d'H. pylori se révèlent utiles en matière de compositions diagnostiques et vaccinales. La Figure représente un alignement de séquence aminoacide de cinq protéines d'Helicobacter pylori.
CA002273199A 1996-12-05 1997-12-05 Sequences nucleotidiques et aminoacides en rapport avec helicobacter pylori et compositions vaccinales correspondantes Abandoned CA2273199A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US75962596A 1996-12-05 1996-12-05
US82374597A 1997-03-25 1997-03-25
US89192897A 1997-07-14 1997-07-14
US08/891,928 1997-07-14
US08/823,745 1997-07-14
US08/759,625 1997-07-14
PCT/US1997/022104 WO1998024475A1 (fr) 1996-12-05 1997-12-05 Sequences nucleotidiques et aminoacides en rapport avec helicobacter pylori et compositions vaccinales correspondantes

Publications (1)

Publication Number Publication Date
CA2273199A1 true CA2273199A1 (fr) 1998-06-11

Family

ID=27419527

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002273199A Abandoned CA2273199A1 (fr) 1996-12-05 1997-12-05 Sequences nucleotidiques et aminoacides en rapport avec helicobacter pylori et compositions vaccinales correspondantes

Country Status (18)

Country Link
EP (1) EP0964699A4 (fr)
JP (1) JP2001510992A (fr)
KR (1) KR20000069297A (fr)
CN (1) CN1246799A (fr)
AR (1) AR010337A1 (fr)
AU (1) AU739641B2 (fr)
BR (1) BR9714133A (fr)
CA (1) CA2273199A1 (fr)
EE (1) EE9900226A (fr)
ID (1) ID21946A (fr)
IL (1) IL129746A0 (fr)
IS (1) IS5047A (fr)
NO (1) NO992158L (fr)
NZ (1) NZ335633A (fr)
PL (1) PL333943A1 (fr)
SK (1) SK57999A3 (fr)
TR (1) TR199901262T2 (fr)
WO (1) WO1998024475A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1197965C (zh) * 1998-10-26 2005-04-20 诺维信公司 在丝状真菌细胞内构建和筛选目的dna文库
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
US6951729B1 (en) 1999-10-27 2005-10-04 Affinium Pharmaceuticals, Inc. High throughput screening method for biological agents affecting fatty acid biosynthesis
US7048926B2 (en) 2000-10-06 2006-05-23 Affinium Pharmaceuticals, Inc. Methods of agonizing and antagonizing FabK
AU2000277557A1 (en) * 2000-10-06 2002-04-22 Smith Kline Beecham Corporation Methods of agonizing and antagonizing fabk
WO2002066502A1 (fr) * 2001-02-21 2002-08-29 Boren Thomas Adhesine de liaison de l'acide sialique d'helicobacter pylori, saba et gene de saba
US20120135039A1 (en) * 2008-10-08 2012-05-31 Aldwell Frank E Oral Vaccines for Producing Mucosal Immunity
WO2017102779A1 (fr) * 2015-12-14 2017-06-22 Technische Universität München Vaccins contre helicobacter pylori
CN110343697A (zh) * 2019-08-05 2019-10-18 湖州三零科技股份有限公司 一种植物病害菌总dna提取方法
CN113435168B (zh) * 2021-06-10 2024-03-22 上海美吉生物医药科技有限公司 胶图自动编辑方法、系统、终端及介质
CN114057854B (zh) * 2021-09-30 2022-07-15 河北医科大学第四医院 一种幽门螺杆菌cd4+t细胞耐受多肽融合抗原及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (sv) * 1993-01-19 1994-07-20 Medicarb Ab Framställning av ett nytt läkemedel

Also Published As

Publication number Publication date
EP0964699A1 (fr) 1999-12-22
KR20000069297A (ko) 2000-11-25
SK57999A3 (en) 2000-05-16
AU5895498A (en) 1998-06-29
EE9900226A (et) 1999-12-15
AR010337A1 (es) 2000-06-07
CN1246799A (zh) 2000-03-08
TR199901262T2 (xx) 1999-08-23
BR9714133A (pt) 2000-02-29
PL333943A1 (en) 2000-01-31
AU739641B2 (en) 2001-10-18
NO992158D0 (no) 1999-05-04
IL129746A0 (en) 2000-02-29
NZ335633A (en) 2000-10-27
EP0964699A4 (fr) 2005-04-06
WO1998024475A1 (fr) 1998-06-11
ID21946A (id) 1999-08-12
JP2001510992A (ja) 2001-08-07
NO992158L (no) 1999-07-05
IS5047A (is) 1999-05-10

Similar Documents

Publication Publication Date Title
US7416862B2 (en) Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
EP1203817B1 (fr) Composés et procédés pour l'immunothérapie et le diagnostic de la tuberculose
CA2337638A1 (fr) Composes et methodes pour l'immunotherapie et le diagnostic de la tuberculose
WO1996040893A1 (fr) Sequences d'acide nucleique et d'acides amines concernant helicobacter pylori, utilisees a des fins diagnostiques et therapeutiques
AU2018201768A1 (en) Protein antigens that provide protection against pneumococcal colonization and/or disease
AU2012207089B2 (en) Vaccines and compositions against Streptococcus pneumoniae
CA2321106A1 (fr) Antigenes du streptocoque du groupe b
US20040052799A1 (en) Nucleic acid and amino acid sequences relating to Helicobacter pylori for diagnostics and therapeutics
JP2001501832A (ja) 結核の免疫治療および診断用の化合物および方法
CA2273199A1 (fr) Sequences nucleotidiques et aminoacides en rapport avec helicobacter pylori et compositions vaccinales correspondantes
CA2286306A1 (fr) Identification de polynucleotides codant de nouveaux polypeptides helicobacter dans le genome helicobacter
AU734052B2 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
CA2248985A1 (fr) Acide nucleique et sequence d'acides amines pour lutter contre helicobacter pylori et compositions de vaccins
CA2346218A1 (fr) Vaccin et diagnostic tb selon les antigenes de la cellule du bacille de koch
WO1999021959A2 (fr) FORMULATIONS VACCINALES A BASE DE $i(HELICOBACTER PYLORI)
WO1997019098A9 (fr) Sequences d'acides nucleiques et d'acides amines relatives au codage de helicobacter pylori a des fins diagnostiques et therapeutiques
WO1997019098A1 (fr) Sequences d'acides nucleiques et d'acides amines relatives au codage de helicobacter pylori a des fins diagnostiques et therapeutiques
CA2286893A1 (fr) Polypeptides d'helicobacter de 76 kda, 32 kda et 50 kda et molecules de polynucleotides correspondantes
CA2414125A1 (fr) Operon virb de bartonella henselae et proteines codees par cet operon
AU710880C (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
CA2356764A1 (fr) Vaccin
EP0842270A1 (fr) Sequences d'acide nucleique et d'acides amines concernant helicobacter pylori, utilisees a des fins diagnostiques et therapeutiques
CZ198899A3 (cs) Sekvence nukleových kyselin a aminokyselin související s Helicobacter pylori a vakcínové kompozice z nich připravené
MXPA99004890A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori
CZ148399A3 (cs) Sekvence nukleových kyselin a aminokyselin Helicobacter pylori a vakcinační prostředky

Legal Events

Date Code Title Description
FZDE Discontinued